Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Kim, K. Jin, Li, Bing, Winer, Jane, Armanini, Mark, Gillett, Nancy, Phillips, Heidi S., Ferrara, Napoleone·1993·Nature
DOI 10.1038/362841a0

Cited by (1,006)

Items 201–300 of 1,006

  1. Role of Vascular Endothelial Growth Factor in Ovarian Cancer
    Sam A. Mesiano, Napoleone Ferrara, Robert B. Jaffe · 1998 · American Journal Of Pathology
  2. Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer
    Masakazu Toi, Seigo Hoshina, Toshiaki Takayanagi, Takeshi Tominaga · 1994 · Japanese Journal of Cancer Research
  3. Direct Intramuscular Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor Augments Collateral Development and Tissue Perfusion
    Yukio Tsurumi, Satoshi Takeshita, Dongfen Chen, Marianne Kearney, Susan Rossow, Jonathan J. Passeri, Jeffrey R. Horowitz, James F. Symes, Jeffrey M. Isner · 1996 · Circulation
  4. Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer
    Adrian M. Jubb, Herbert I. Hurwitz, Wei Bai, Eric B. Holmgren, Patti Tobin, Angel Guerrero, Fairooz F. Kabbinavar, Scott N. Holden, William F. Novotny, Gretchen D. Frantz et al. · 2005 · Journal of Clinical Oncology
  5. Reactive Oxygen Species as Downstream Mediators of Angiogenic Signaling by Vascular Endothelial Growth Factor Receptor-2/KDR
    Renata Colavitti, Giovambattista Pani, Barbara Bedogni, Rosanna Anzevino, Silvia Borrello, Johannes L. Waltenberger, Tommaso Galeotti · 2002 · Journal of Biological Chemistry
  6. Vasculogenesis and Angiogenesis as Mechanisms of Vascular Network Formation, Growth and Remodeling
    Sybill Patan · 2000 · Journal of Neuro-Oncology
  7. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Fortunato Ciardiello, Roberto Bianco, V. Damiano, Gabriella Fontanini, R. Caputo, G Pomatico, Sabino De Placido, Angelo Raffaele Bianco, John M. Mendelsohn, Giampaolo Tortora · 2000 · PubMed
  8. A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics
    Yoshifumi Takei, Kenji Kadomatsu, Yukio Yuzawa, Seiichi Matsuo, Takashi Muramatsu · 2004 · Cancer Research
  9. Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude Mice
    Junya Yoneda, Hiroki Kuniyasu, Janet E. Price, Corazon D. Bucana, Isaiah J. Fidler, Marta Ann Crispens · 1998 · JNCI Journal of the National Cancer Institute
  10. VEGF: an update on biological and therapeutic aspects
    Napoleone Ferrara · 2000 · Current Opinion in Biotechnology
  11. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis
    Seiji Takashima, Masafumi Kitakaze, Masanori Asakura, Hiroshi Asanuma, Shoji Sanada, Fumi Tashiro, Hitoshi Niwa, Jun‐ichi Miyazaki, Seiichi Hirota, Yukihiko Kitamura et al. · 2002 · Proceedings of the National Academy of Sciences
  12. Angiogenesis and hepatocellular carcinoma
    David Semela, Jean‐François Dufour · 2004 · Journal of Hepatology
  13. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
    Pengnian Charles Lin, Jake A. Buxton, Ann L. Acheson, Czeslaw H. Radziejewski, Peter C. Maisonpierre, George D. Yancopoulos, Keith M. Channon, Laura P. Hale, Mark W. Dewhirst, Samuel E. George et al. · 1998 · Proceedings of the National Academy of Sciences
  14. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.
    Suyun Huang, Jubilee B. Robinson, Ariel DeGuzman, Corazon D. Bucana, Isaiah J. Fidler · 2000 · PubMed
  15. Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
    Leonard R. Henry, Hyung‐Ok Lee, John S. Lee, Andres J. Klein–Szanto, Perry Watts, Eric A. Ross, Wen‐Tien Chen, Jonathan D. Cheng · 2007 · Clinical Cancer Research
  16. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Lawrence F. Brown, Anthony J. Guidi, Stuart J. Schnitt, Livingston Van De Water, M. Luisa Iruela‐Arispe, Tet Kin Yeo, Kathi Tognazzi, Harold F. Dvorak · 1999 · PubMed
  17. Estimating the prevalence of cancer in the United States
    Anthony P. Polednak · 1997 · Cancer
  18. Mathematical modeling of tumor-induced angiogenesis
    Nikos V. Mantzaris, Steve Webb, Hans G. Othmer · 2004 · Journal of Mathematical Biology
  19. Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data
    Kim Allyson Margolin, Michael S. Gordon, Eric B. Holmgren, Jacques Gaudreault, William F. Novotny, G. Fyfe, Daniel C. Adelman, Susan Stalter, J. Breed · 2001 · Journal of Clinical Oncology
  20. Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance
    Mu‐En Lin, Deron Raymond Herr, Jerold J. M. Chun · 2009 · Prostaglandins & Other Lipid Mediators
  21. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
    Masakazu Toi, Kazuo Inada, Hideo Suzuki, Takeshi Tominaga · 1995 · Breast Cancer Research and Treatment
  22. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
    Axel Grothey, Evanthia Galanis · 2009 · Nature Reviews Clinical Oncology
  23. Vascular endothelial growth factor
    Napoleone Ferrara · 1996 · European Journal of Cancer
  24. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
    Douglas A. Arenberg, Steven L. Kunkel, Peter J. Polverini, S B Morris, Marie D. Burdick, Mary Glass, Dennis D. Taub, Mark D. Iannettoni, Richard I. Whyte, Robert M. Strieter · 1996 · The Journal of Experimental Medicine
  25. Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.
    Goel, S., Wong, A. H.-K., Jain, R. K. · 2012 · Cold Spring Harbor Perspectives in Medicine
  26. Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen
    David T. Shima, Anthony P. Adamis, Napoleone Ferrara, Kiang-Teck Yeo, Tet-Kin Yeo, Rapheal Allende, Judah Folkman, Patrìcia A. D'Amore · 1995 · Molecular Medicine
  27. Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.
    Daniele Santini, Bruno Vincenzi, Giordano Dicuonzo, Giuseppe Avvisati, Cristian Massacesi, Fabrizio Battistoni, Michele Gavasci, Laura Rocci, Maria Cristina Tirindelli, Vittorio Altomare et al. · 2003 · PubMed
  28. Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
    Yoshiro Itatani, Kenji Kawada, Takamasa S. Yamamoto, Yoshiharu Sakai · 2018 · International Journal of Molecular Sciences
  29. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
    Chengying Xie, Xiaozhe Wan, Haitian Quan, Mingyue Zheng, Fu Li, Yun Li, Liguang Lou · 2018 · Cancer Science
  30. Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal Administration
    Joyce J. Mordenti, R. Andrew Cuthbertson, Napoleone Ferrara, Karen Thomsen, Lea T. Berleau, Vojtech Ličko, Philip C. Allen, Celia R. Valverde, Y. Gloria Meng, David T.W. Fei et al. · 1999 · Toxicologic Pathology
  31. Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
    Farbod Shojaei · 2012 · Cancer Letters
  32. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.
    Joan W. Miller, Anthony P. Adamis, David T. Shima, Patrìcia A. D'Amore, Rachel S. Moulton, M S O'Reilly, Judah Folkman, Harold F. Dvorak, L F Brown, Brygida Berse · 1994 · PubMed Central
  33. Vascular Endothelial Growth Factor-C (VEGF-C/VEGF-2) Promotes Angiogenesis in the Setting of Tissue Ischemia
    Bernhard Witzenbichler, Takayuki Asahara, Toyoaki Murohara, Marcy Silver, Ioakim Spyridopoulos, Meredith Magner, Nicole Principe, Marianne Kearney, Jing‐Shan Hu, Jeffrey M. Isner · 1998 · American Journal Of Pathology
  34. Angiogenesis—a new target for future therapy
    Nilesh M. Pandya, Naranjan S. Dhalla, Dev D. Santani · 2006 · Vascular Pharmacology
  35. Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF
    Wei‐Ching Liang, Xiumin Wu, Franklin V. Peale Jr., Chingwei V. Lee, Y. Gloria Meng, Johnny Gutierrez, Ling Fu, Ajay K. Malik, Hans‐Peter Gerber, Napoleone Ferrara et al. · 2005 · Journal of Biological Chemistry
  36. Induction of Vascular Endothelial Growth Factor Gene Expression by Interleukin-1 β in Rat Aortic Smooth Muscle Cells
    Jian Li, Mark A. Perrella, Jer‐Chia Tsai, Shaw‐Fang Yet, Chung-Ming Hsieh, Masao Yoshizumi, Cam Patterson, Wilson O. Endege, Fen Zhou, Mu-En Lee · 1995 · Journal of Biological Chemistry
  37. Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF165 via Its Exon 7-encoded Domain
    Shay Söker, Herman Fidder, Gera Neufeld, Michael Klagsbrun · 1996 · Journal of Biological Chemistry
  38. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
    Klaus Podar, Kenneth Carl Anderson · 2004 · Blood
  39. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes
    William T. Bellamy, Lynne C. Richter, Davuud Sirjani, Concepcion Roxas, Betty Glinsmann‐Gibson, Yvette M. Frutiger, Thomas M. Grogan, Alan F. List · 2001 · Blood
  40. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.
    Shi‐Yuan Cheng, Hui Huang, Motoo Nagane, Xiang-Dong Ji, D Wang, Chao-Ming Shih, Wadih Arap, Chun-Ming Huang, Webster K. Cavenee · 1996 · Proceedings of the National Academy of Sciences
  41. Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease
    Arvind Kant Pandey, Eric Kumar Singhi, Juan Pablo Arroyo, Talat Alp Ikizler, Edward R. Gould, Jonathan D. Brown, Joshua A. Beckman, David Glenn Harrison, Javid J. Moslehi · 2017 · Hypertension
  42. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration
    2003 · Ophthalmology
  43. Angiogenesis in malignant gliomas
    Karl Heinz Plate, Werner Risau · 1995 · Glia
  44. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.
    G.S. Robinson, Eric A. Pierce, Susan L. Rook, E Foley, R Webb, Lois E. H. Smith · 1996 · Proceedings of the National Academy of Sciences
  45. Endothelial Cell Metabolism in Health and Disease
    Kateřina Rohlenová, Koen Veys, Ines Miranda Santos, Katrien De Bock, Peter Carmeliet · 2017 · Trends in Cell Biology
  46. An enzyme-linked oligonucleotide assay
    Daniel W. Drolet, L Moon-McDermott, Timothy S. Romig · 1996 · Nature Biotechnology
  47. Vascular endothelial growth factor signaling in development and disease
    Sinem Karaman, Veli‐Matti Leppänen, Kari K. Alitalo · 2018 · Development
  48. THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE
    Anthony P. Adamis, David T. Shima · 2005 · Retina
  49. Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
    Hans P. M. W. Wildiers, Gunter Guetens, Gert De Boeck, Eric K. Verbeken, Bart Landuyt, Willy Landuyt, Ernst A. de Bruijn, A.T. van Oosterom · 2003 · British Journal of Cancer
  50. Marked Induction of the IAP Family Antiapoptotic Proteins Survivin and XIAP by VEGF in Vascular Endothelial Cells
    Jennifer Tran, Janusz W. Rak, Capucine Sheehan, Samuel David Saibil, Eric Charles LaCasse, Robert G. Korneluk, Robert S. Kerbel · 1999 · Biochemical and Biophysical Research Communications
  51. Targeting CCL2 with Systemic Delivery of Neutralizing Antibodies Induces Prostate Cancer Tumor Regression In vivo
    Robert D. Loberg, Ying Chi, Matt Craig, Lashon L. Day, Erin Sargent, Chris K. Neeley, Kirk J. Wojno, Linda A. Snyder, Yan Li, Kenneth J. Pienta · 2007 · Cancer Research
  52. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.
    Pedro F. Lopez, B D Sippy, H. Michael Lambert, A B Thach, David R. Hinton · 1996 · PubMed
  53. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo
    Christopher M. Cox, Susan L. D'Agostino, Melanie K. Miller, Ronald L. Heimark, Paul A. Krieg · 2006 · Developmental Biology
  54. Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
    Roy Martin Bremnes, Carlos Camps, Rafael Sirera · 2005 · Lung Cancer
  55. Vascular Endothelial Growth Factor Is Sufficient to Produce Iris Neovascularization and Neovascular Glaucoma in a Nonhuman Primate
    Michael J. Tolentino · 1996 · Archives of Ophthalmology
  56. The reactive stroma microenvironment and prostate cancer progression
    David A. Barron, David R. Rowley · 2012 · Endocrine Related Cancer
  57. Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors
    Petri Salvén, Athina Lymboussaki, Päivi Heikkilä, Hilkka A. Jääskelä-Saari, Berndt Enholm, Karin Aase, Gabriel von Euler, Ulf Eriksson, Kari K. Alitalo, Heikki Joensuu · 1998 · American Journal Of Pathology
  58. The Mouse Gene for Vascular Endothelial Growth Factor
    David T. Shima, Masatoshi Kuroki, Urban Deutsch, Yin‐Shan Ng, Anthony P. Adamis, Patrìcia A. D'Amore · 1996 · Journal of Biological Chemistry
  59. Targeted Drug Delivery in Cancer Therapy
    Jaspreet K. Vasir, Vinod D. Labhasetwar · 2005 · Technology in Cancer Research & Treatment
  60. Effects of Interferon Alpha on Vascular Endothelial Growth Factor Gene Transcription and Tumor Angiogenesis
    Zofia von Marschall, A. Scholz, Thorsten Cramer, G. Schafer, Michael Schirner, Kjell Öberg, Bertram J. Wiedenmann, Michael R. Höcker, Stefan Rosewicz · 2003 · JNCI Journal of the National Cancer Institute
  61. Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.
    Fortunato Ciardiello, Rosa Caputo, Vincenzo Damiano, Roberta Caputo, Teresa Troiani, Donatella Vitagliano, Francesca Carlomagno, Bianca Maria Veneziani, Gabriella Fontanini, A R Bianco et al. · 2003 · PubMed
  62. VEGF-A: a critical regulator of blood vessel growth
    Napoleone Ferrara · 2009 · European Cytokine Network
  63. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Susanne Wizigmann-Voos, Georg Breier, Werner Risau, Karl Heinz Plate · 1995 · PubMed
  64. Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
    Olivia G. Taylor, Joshua S. Brzozowski, Kathryn Anne Skelding · 2019 · Frontiers in Oncology
  65. Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer
    Giampietro Gasparini · 2000 · The Oncologist
  66. Role of Vegf-Flt Receptor System in Normal and Tumor Angiogenesis
    Masabumi Shibuya · 1995 · Advances in cancer research
  67. Angiogenesis inhibition: A review
    Wanda Auerbach, Robert Auerbach · 1994 · Pharmacology & Therapeutics
  68. Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins
    Christopher G. Kevil, D. Keith Payne, Elizabeth Mire, J. Steven Alexander · 1998 · Journal of Biological Chemistry
  69. Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression
    Rong Shao, Shideng Bao, Xuefang Bai, Carrie Blanchette, Ryan M. Anderson, Tongyun Dang, Mikhail L. Gishizky, Jeffrey R. Marks, Xiao-Fan Wang · 2004 · Molecular and Cellular Biology
  70. In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes
    Nghiem Doan, Peter Reher, S Meghji, Malcolm Harris · 1999 · Journal of Oral and Maxillofacial Surgery
  71. Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab
    William L. Ince, Adrian M. Jubb, Scott N. Holden, Eric B. Holmgren, Patti Tobin, Meera Sridhar, Herbert I. Hurwitz, Fairooz F. Kabbinavar, William F. Novotny, Kenneth J. Hillan et al. · 2005 · JNCI Journal of the National Cancer Institute
  72. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
    Elia J. Duh, Lloyd Paul Aiello · 1999 · Diabetes
  73. Flk-1 as a target for tumor growth inhibition.
    Laurie M. Strawn, Gerald McMahon, Harald App, Randall Schreck, W R Kuchler, M P Longhi, T H Hui, Cho Tang, Alexander Levitzki, Aviv Gazit et al. · 1996 · PubMed
  74. Prognostic significance of angiogenesis in human pancreatic cancer
    Naoya Ikeda, M Adachi, Toshihiko Taki, Cheng‐long Huang, Hiroki Hashida, Arimichi Takabayashi, Masayuki Sho, Y. Nakajima, H Kanehiro, M Hisanaga et al. · 1999 · British Journal of Cancer
  75. Pathways mediating VEGF-independent tumor angiogenesis
    Napoleone Ferrara · 2009 · Cytokine & Growth Factor Reviews
  76. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity
    Michael L. Gagnon, Diane Renee Bielenberg, Ze’ev Gechtman, Hua‐Quan Miao, Seiji Takashima, Shay Söker, Michael Klagsbrun · 2000 · Proceedings of the National Academy of Sciences
  77. Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression
    Hua‐Quan Miao, Percy P. Lee, Hank Lin, Shay Söker, Michael Klagsbrun · 2000 · The FASEB Journal
  78. The role of VEGF in the regulation of physiological and pathological angiogenesis
    Napoleone Ferrara · 2005 · Birkhäuser Basel eBooks
  79. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family.
    Maurizio Orlandini, Lucia Marconcini, R Ferruzzi, Salvatore Oliviero · 1996 · Proceedings of the National Academy of Sciences
  80. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Michael Sean Wiesener, Philine Münchenhagen, Irina Berger, Neil V. Morgan, Jan Roigas, Andreas Schwiertz, Jan Steffen Jürgensen, Guenther Gruber, Patrick Henry Maxwell, S A Löning et al. · 2001 · PubMed
  81. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Angelika Eggert, Naohiko Ikegaki, Janet L. Kwiatkowski, Huaqing Zhao, Garrett M. Brodeur, Bruce P. Himelstein · 2000 · PubMed
  82. Intra-tumoural microvessel density in human solid tumours
    Jurjees Hasan, Richard J. Byers, Gordon C. Jayson · 2002 · British Journal of Cancer
  83. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Rolf A. Brekken, Jay P. Overholser, Victor Stastny, Johannes L. Waltenberger, John Dorrance Minna, Philip E. Thorpe · 2000 · PubMed
  84. Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
    Sandra E. Pike, Lei Yao, Karen D. Jones, Barry Cherney, Ettore Appella, Kazuyasu Sakaguchi, Hira Lal Nakhasi, Julie Teruya‐Feldstein, Peter J. Wirth, Ghanshyam Gupta et al. · 1998 · The Journal of Experimental Medicine
  85. Breast Cancer Metastasis
    Natascia Marino, Stephan Woditschka, L. Tiffany Reed, Joji Nakayama, Musa Mayer, Maria Wetzel, Patricia Schriver Steeg · 2013 · American Journal Of Pathology
  86. Amelioration of Long-Term Renal Changes in Obese Type 2 Diabetic Mice by a Neutralizing Vascular Endothelial Growth Factor Antibody
    Allan Flyvbjerg, Frederik Dagnæs‐Hansen, An S. De Vriese, Bieke F. Schrijvers, Ronald G. Tilton, Ruth Rasch · 2002 · Diabetes
  87. Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy
    Larry Witte, Daniel J. Hicklin, Zhenping Zhu, Bronislaw Pytowski, Helen Kotanides, Patricia Rockwell, Peter Böhlen · 1998 · Cancer and Metastasis Reviews
  88. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
    Amit M. Maity, Nabendu Pore, Jerry S. H. Lee, Don Solomon, Donald M. O’Rourke · 2000 · PubMed
  89. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
    M Mise, Shigeki Arii, Hiroaki Higashituji, M Furutani, M Niwano, Tomika Harada, S Ishigami, Yoshinobu Toda, H Nakayama, M Fukumoto et al. · 1996 · Hepatology
  90. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
    Erwin G. Van Meir, Peter J. Polverini, Victoria R. Chazin, Hui Huang, Nicolas de Tribolet, Webster K. Cavenee · 1994 · Nature Genetics
  91. Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
    Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Alicja Chrzanowska, Tomasz Lorenc · 2020 · International Journal of Molecular Sciences
  92. A comprehensive review of protein kinase inhibitors for cancer therapy
    Radhamani Kannaiyan, Daruka Mahadevan · 2018 · Expert Review of Anticancer Therapy
  93. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas.
    Akihiro Nishie, Masahiro Ono, T Shono, Jun‐ichi Fukushi, Michihiro Otsubo, H Onoue, Yushi Ito, Takanori Inamura, 池崎 清信, M Fukui et al. · 1999 · PubMed
  94. Molecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D
    Yoshiki Yamada, Jun‐ichi Nezu, Miyuki Shimane, Yuichi Hirata · 1997 · Genomics
  95. Developing aptamers into therapeutics
    Rebekah Ruth White, Bruce A. Sullenger, Christopher P. Rusconi · 2000 · Journal of Clinical Investigation
  96. Pathogenesis of retinopathy of prematurity
    Lois E. H. Smith · 2003 · Seminars in Neonatology
  97. Identification of a peptide blocking vascular endothelial growth factor (VEGF)‐mediated angiogenesis
    Roselyne Tournaire, Caroline Demangel, Bernard A. Malavaud, Roger Vassy, Sylvie Rouyre, M Kraemer, Jean Plouët, Claude Derbin, Gérard Yves Perret, Jean Claude Mazié · 2000 · The EMBO Journal
  98. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.
    Qian Shi, Xiangdong Le, James L. Abbruzzese, Zhihai Peng, Chao‐Nan Qian, Hong Wei Tang, Qinghua Xiong, Bailiang Wang, Xiang Chen Li, Keping Xie · 2001 · PubMed
  99. Expression of calpain I messenger RNA in human renal cell carcinoma: Correlation with lymph node metastasis and histological type
    Christian Braun, Matthias Engel, Markus Seifert, Birgit Theisinger, Gerhard Seitz, K. D. Zang, Cornelius Welter · 1999 · International Journal of Cancer
  100. VEGF‐null cells require PDGFR α signaling‐mediated stromal fibroblast recruitment for tumorigenesis
    Jianying Dong, Jeremy Grunstein, Max L. Tejada, Frank Peale, Gretchen D. Frantz, Wei‐Ching Liang, Wei Bai, Lanlan Yu, Joe Kowalski, Xiao‐Huan Liang et al. · 2004 · The EMBO Journal